In a study by Elhai et al., in vivo blockade of OX40L in murine models of SSc prevented the inflammation-driven fibrosis, fibrosing alveolitis, and lung vessel remodeling normally associated with this model (148). This evidence concerns the gene TNFSF4 and systemic sclerosis.